Small Molecule Targeted Cancer Therapy Market Size, Share, Trends, Growth Report 2032
Small Molecule Targeted Cancer Therapy Market By Type (Small Molecule Drug Conjugates, Small Molecules (Small Molecule Cyclin-Dependent Kinase Inhibitor, Small Molecule Proteasome Inhibitor, Small Molecule Tyrosine Kinase Inhibitor), And Monoclonal Antibodies(Fully Human Antibody, Chimeric Monoclonal Antibody, Humanized Monoclonal Antibody)), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 83.41 Billion | USD 188.78 Billion | 9.50% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Small Mulecule Targeted Cancer Therapy Market, 2016 - 2025, (USD Million)
- 2.2. Small Mulecule Targeted Cancer Therapy Market: Snapshot
- Chapter 3. Global Small Mulecule Targeted Cancer Therapy Market – Industry Analysis
- 3.1. Small Mulecule Targeted Cancer Therapy Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Growing Demand for Targeted Therapy with Lesser Side Effects over Chemotherapy
- 3.2.2. Increasing Cancer Prevalence
- 3.3. Restraints
- 3.3.1. Longer Drug Approval Time and Stringent Regulatory Requirements
- 3.4. Opportunity
- 3.4.1. Patent Expiry of Major Drugs
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis by type segment
- 3.6.2. Market attractiveness analysis by regional segment
- Chapter 4. Global Small Mulecule Targeted Cancer Therapy Market - Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global small mulecule targeted cancer therapy market: company market share analysis, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New type launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and regional expansion
- 4.1. Company market share analysis
- Chapter 5. Global Small Mulecule Targeted Cancer Therapy Market – Type Segment Analysis
- 5.1. Global small mulecule targeted cancer therapy market overview: by type
- 5.1.1. Global small mulecule targeted cancer therapy market revenue share, by type, 2018 and 2025
- 5.2. Monoclonal Antibodies
- 5.2.1. Global small mulecule targeted cancer therapy market by Monoclonal Antibodies, 2016-2025 (USD Million)
- 5.3. Small Mulecules
- 5.3.1. Global small mulecule targeted cancer therapy market by Small Mulecules, 2016-2025 (USD Million)
- 5.4. Small Mulecule Drug Conjugates
- 5.4.1. Global small mulecule targeted cancer therapy market by Small Mulecule Drug Conjugates, 2016-2025 (USD Million)
- 5.1. Global small mulecule targeted cancer therapy market overview: by type
- Chapter 6. Global Small Mulecule Targeted Cancer Therapy Market - Regional Analysis
- 6.1. Global small mulecule targeted cancer therapy market overview: by region
- 6.1.1. Global small mulecule targeted cancer therapy market revenue share, by region, 2018 and 2025
- 6.2. North America
- 6.2.1. North America small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
- 6.2.2. North America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.2.3. The U.S.
- 6.2.3.1. The U.S. small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.2.4. Rest of North America
- 6.2.4.1. Rest of North America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.3. Europe
- 6.3.1. Europe small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
- 6.3.2. Europe small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.3.3. U.K.
- 6.3.3.1. U.K. small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.3.4. France
- 6.3.4.1. France small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.3.5. Germany
- 6.3.5.1. Germany small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.3.6. Rest of Europe
- 6.3.6.1. Rest of Europe small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
- 6.4.2. Asia Pacific small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.4.3. China
- 6.4.3.1. China small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.4.4. Japan
- 6.4.4.1. Japan small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.4.5. India
- 6.4.5.1. India small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.4.6. Rest of Asia Pacific
- 6.4.6.1. Rest of Asia Pacific small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America small mulecule targeted cancer therapy market, by country, 2016-2025 (USD Million)
- 6.5.2. Latin America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.5.3. Brazil
- 6.5.3.1. Brazil small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.5.4. Rest of Latin America
- 6.5.4.1. Rest of Latin America small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.6. Middle East & Africa
- 6.6.1. Middle East & Africa small mulecule targeted cancer therapy market, 2016-2025 (USD Million)
- 6.6.2. Middle East & Africa small mulecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
- 6.1. Global small mulecule targeted cancer therapy market overview: by region
- Chapter 7. Company Profiles
- 7.1. Abbott Laboratories
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Type Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Boehringer Ingelheim GmbH
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Type Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Bayer HealthCare AG
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Type Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. GlaxoSmithKline plc
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Type Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Hospira Inc.
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Type Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Developments
- 7.6. Cytokinetics Inc.
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Type Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Developments
- 7.7. OncoGenex Pharmaceuticals, Inc.
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Type Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Developments
- 7.1. Abbott Laboratories
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global small molecule targeted cancer therapy market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: small molecule targeted cancer therapy market
5. Global small molecule targeted cancer therapy market attractiveness, by type
6. Global small molecule targeted cancer therapy market revenue share, by type, 2018 and 2025
7. Global small molecule targeted cancer therapy market by monoclonal antibodies, 2016-2025 (USD Million)
8. Global small molecule targeted cancer therapy market by small molecules, 2016-2025 (USD Million)
9. Global small molecule targeted cancer therapy market by small molecule drug conjugates, 2016-2025 (USD Million)
10. Global small molecule targeted cancer therapy market revenue share, by region, 2018 & 2025
11. North America small molecule targeted cancer therapy market, 2016-2025 (USD Million)
12. Europe small molecule targeted cancer therapy market, 2016-2025 (USD Million)
13. Asia Pacific small molecule targeted cancer therapy market, 2016-2025 (USD Million)
14. Latin America small molecule targeted cancer therapy market, 2016-2025 (USD Million)
15. Middle East & Africa small molecule targeted cancer therapy market, 2016-2025 (USD Million)
Table Of Tables
List of Tables
1. Global small molecule targeted cancer therapy market: snapshot
2. Drivers for small molecule targeted cancer therapy market: impact analysis
3. Restraints for small molecule targeted cancer therapy market: impact analysis
4. North America small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
5. North America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
6. North America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
7. North America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
8. The U.S. small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
9. The U.S. small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
10. The U.S. small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
11. Rest of North America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
12. Rest of North America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
13. Rest of North America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
14. Europe small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
15. Europe small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
16. Europe small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
17. Europe small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
18. U.K. small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
19. U.K. small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
20. U.K. small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
21. France small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
22. France small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
23. France small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
24. Germany small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
25. Germany small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
26. Germany small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
27. Rest of Europe small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
28. Rest of Europe small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
29. Rest of Europe small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
30. Asia Pacific small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
31. Asia Pacific small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
32. Asia Pacific small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
33. Asia Pacific small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
34. China small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
35. China small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
36. China small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
37. Japan small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
38. Japan small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
39. Japan small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
40. India small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
41. India small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
42. India small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
43. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
44. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
45. Rest of Asia Pacific small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
46. Latin America small molecule targeted cancer therapy market revenue, by country, 2016-2025 (USD Million)
47. Latin America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
48. Latin America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
49. Latin America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
50. Brazil small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
51. Brazil small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
52. Brazil small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
53. Rest of Latin America small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
54. Rest of Latin America small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
55. Rest of Latin America small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
56. Middle East & Africa small molecule targeted cancer therapy market revenue, by type, 2016-2025 (USD Million)
57. Middle East & Africa small molecule targeted cancer therapy market revenue, by small molecules, 2016-2025 (USD Million)
58. Middle East & Africa small molecule targeted cancer therapy market revenue, by monoclonal antibodies, 2016-2025 (USD Million)
Methodology
FrequentlyAsked Questions
Small molecule targeted cancer therapy targets and inhibits cancer cell growth utilizing low-molecular-weight drugs. Unlike typical chemotherapy, which affects both healthy and malignant cells, targeted therapy disrupts signaling pathways or chemicals essential for cancer cell survival and proliferation.
The demand for small molecule targeted cancer therapy market is driven by growing preference for cancer therapies with minimal adverse events, increasing cancer prevalence and increasing awareness.
According to the report, he Global small molecule targeted cancer therapy market size was worth around USD 83.41? Billion in 2023 and is estimated to grow to about USD 188.78 Billion by 2032, with a compound annual growth rate (CAGR) of approximately 9.50% over the forecast period.
North America has been leading the global small molecule targeted cancer therapy market and is anticipated to continue on the dominant position in the years to come.
Major players included in the report are Abbott Laboratories, Bayer HealthCare AG, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Hospira Inc., Cytokinetics Inc. and OncoGenex Pharmaceuticals, Inc. among others.
Choose License Type
List of Contents
Small Molecule Targeted Cancer TherapySizeSmall Molecule Targeted Cancer TherapyOverviewSmall Molecule Targeted Cancer TherapyMarket:Growth FactorsSmall Molecule Targeted Cancer TherapySegmentationSmall Molecule Targeted Cancer TherapyReport Scope:Small Molecule Targeted Cancer TherapyMarket:Regional InsightsSmall Molecule Targeted Cancer TherapyMarket:Competitive PlayersThe report segment of global small molecule targeted cancer therapy market as follows:RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed